This inventor holds 1 USPTO granted patent. Top assignee: Cempra Pharmaceuticals, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations in Bacterial Infection Treatment by Ronald Norman Jones
Introduction
Ronald Norman Jones is an accomplished inventor based in Silverton, Oregon. He has made significant contributions to the field of medicine, particularly in the treatment of bacterial infections. His innovative approach to dosing regimens has the potential to change how these infections are managed.
Latest Patents
Jones holds a patent for "Fusidic acid dosing regimens for treatment of bacterial infections." This patent describes novel dosing regimens that utilize fusidic acid for the treatment and prevention of bacterial infections. His research indicates that a high loading dose of fusidic acid, followed by moderate maintenance doses, can prevent the development of drug-resistant strains of bacteria. Additionally, this method increases the effective spectrum of the drug and minimizes the nausea and vomiting often associated with prolonged high-dose therapy.
Career Highlights
Jones is currently associated with Cempra Pharmaceuticals, Inc., where he continues to work on innovative solutions for bacterial infections. His career is marked by a commitment to improving patient outcomes through scientific research and development.
Collaborations
(Section skipped due to space constraints)
Conclusion
Ronald Norman Jones's work in developing effective dosing regimens for fusidic acid represents a significant advancement in the treatment of bacterial infections. His contributions are poised to enhance therapeutic strategies and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile